Emend and Abnormal behavior - a phase IV clinical study of FDA data
Summary:
We study 65,048 people who take Emend (aprepitant) or have Abnormal behavior. No report of Abnormal behavior is found in people who take Emend.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Emend?
Emend has active ingredients of aprepitant. It is often used in nausea. eHealthMe is studying from 13,741 Emend users. Check the latest studies of Emend.
What is Abnormal Behavior?
Abnormal behavior is found to be associated with 1,381 drugs and 1,941 conditions by eHealthMe. Check the latest studies of Abnormal behavior.
No report is found.
Do you take Emend and have Abnormal behavior?
- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Emend:
- Emend (13,741 reports)
Abnormal behavior treatments and more:
- Abnormal behavior (51,307 reports)
How severe was Abnormal behavior and when was it recovered:
Expand to all the drugs that have ingredients of aprepitant:
Browse all side effects of Emend:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abnormal behavior:
Browse all the conditions that are associated with Abnormal behavior:
How the study uses the data?
The study uses data from the FDA. It is based on aprepitant (the active ingredients of Emend) and Emend (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zopiclone and Linzess - 3 seconds ago
- Hydrocodone Bitartrate And Acetaminophen vs. Elavil, side effect and effectiveness comparison - 6 seconds ago
- Weight Increased and Pain In Extremity - 6 seconds ago
- Drug interactions of Chantix and Synthroid - 6 seconds ago
- Could Amoxicillin cause Venous Thrombosis Deep Limb? - 6 seconds ago
- Drug interactions of Anoro Ellipta and Ibuprofen - 11 seconds ago
- Vitamin B12 Deficiency and Back Pain - 14 seconds ago
- Urinary Tract Infection and Depression Aggravated - 17 seconds ago
- Urinary Tract Infection and Thrombocytopenia - 17 seconds ago
- Dopamine Hydrochloride vs. Lexapro, side effect and effectiveness comparison - 18 seconds ago